Plasmacytoid Dendritic Cells Are Crucial in Bifidobacterium adolescentis-Mediated Inhibition of Yersinia enterocolitica Infection

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wittmann, Alexandra ^a,b   Autenrieth, Ingo B ^a,b   Frick, Julia Stefanie ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; STREPTOMYCIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL STRAIN; BIFIDOBACTERIUM ADOLESCENTIS; CD4 LYMPHOCYTE PERCENTAGE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; REGULATORY T LYMPHOCYTE; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ANIMALS; ANTIBIOSIS; ANTIBODIES; BIFIDOBACTERIUM; BODY WEIGHT; DENDRITIC CELLS; FEMALE; IMMUNITY, INNATE; IMMUNOMODULATION; MICE; MICE, INBRED C57BL; PROBIOTICS; SPLEEN; T-LYMPHOCYTES, REGULATORY; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 84882714002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071338     Document Type: Article

References (65)

1. Bottone EJ, (1999) Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect 1: 323-333.
2. Cover TL, Aber RC, (1989) Yersinia enterocolitica. NEnglJMed 321: 16-24.
3. Cornelis GR, (1994) Yersinia pathogenicity factors. CurrTopMicrobiolImmunol 192: 243-263.
4. Schindler MK, Schutz MS, Muhlenkamp MC, Rooijakkers SH, Hallstrom T, et al. (2012) Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol 189: 4900-4908.
5. De La Cochetiere MF, Durand T, Lalande V, Petit JC, Potel G, et al. (2008) Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. MicrobEcol 56: 395-402.
6. Dethlefsen L, Huse S, Sogin ML, Relman DA, (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoSBiol 6: e280.
7. Jernberg C, Lofmark S, Edlund C, Jansson JK, (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISMEJ 1: 56-66.
8. Lofmark S, Jernberg C, Jansson JK, Edlund C, (2006) Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. JAntimicrobChemother 58: 1160-1167.
9. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. InfectImmun 77: 2367-2375.
10. Yap IK, Li JV, Saric J, Martin FP, Davies H, et al. (2008) Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. JProteomeRes 7: 3718-3728.
11. Sekirov I, Russell SL, Antunes LC, Finlay BB, (2010) Gut microbiota in health and disease. Physiol Rev 90: 859-904.
12. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell HostMicrobe 2: 204.
13. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, et al. (2008) Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455: 804-807.
14. Gradel KO, Schonheyder HC, Kristensen B, Dethlefsen C, Ejlertsen T, et al. (2009) Are host characteristics or exposure factors mainly involved in the acquisition of zoonotic Salmonella and Campylobacter coinfection in humans? FoodbornePathogDis 6: 251-255.
15. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. InfectImmun 71: 2839-2858.
16. Frick JS, Autenrieth IB (2012) The Gut Microflora and Its Variety of Roles in Health and Disease. Curr Top Microbiol Immunol.
17. Senok AC, Ismaeel AY, Botta GA, (2005) Probiotics: facts and myths. ClinMicrobiolInfect 11: 958-966.
18. Gionchetti P, Rizzello F, Venturi A, Campieri M, (2000) Probiotics in infective diarrhoea and inflammatory bowel diseases. JGastroenterolHepatol 15: 489-493.
19. Weichert S, Schroten H, Adam R, (2012) The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases. Pediatr Infect Dis J 31: 859-862.
20. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, et al. (2007) Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335: 340.
21. Nomoto K, (2005) Prevention of infections by probiotics. JBiosciBioeng 100: 583-592.
22. Schlitzer A, Heiseke AF, Einwachter H, Reindl W, Schiemann M, et al. (2012) Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood 119: 6063-6071.
23. Iwasaki A, (2007) Mucosal dendritic cells. Annual review of immunology 25: 381-418.
24. Kraehenbuhl JP, Neutra MR, (2000) Epithelial M cells: differentiation and function. Annual review of cell and developmental biology 16: 301-332.
25. Niess JH, Brand S, Gu X, Landsman L, Jung S, et al. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
26. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, et al. (2009) Origin of the lamina propria dendritic cell network. Immunity 31: 513-525.
27. del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Forster R, (2010) Development and functional specialization of CD103+ dendritic cells. Immunol Rev 234: 268-281.
28. Wendland M, Czeloth N, Mach N, Malissen B, Kremmer E, et al. (2007) CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proceedings of the National Academy of Sciences of the United States of America 104: 6347-6352.
29. Villadangos JA, Young L, (2008) Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29: 352-361.
30. Baumgart DC, Metzke D, Guckelberger O, Pascher A, Grotzinger C, et al. (2011) Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. Clin Exp Immunol 166: 46-54.
31. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, et al. (2004) Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. JImmunol 173: 4433-4442.
32. Matta BM, Castellaneta A, Thomson AW, (2010) Tolerogenic plasmacytoid DC. Eur J Immunol 40: 2667-2676.
33. Frick JS, Fink K, Kahl F, Niemiec MJ, Quitadamo M, et al. (2007) Identification of commensal bacterial strains modulating Yersinia and DSS-induced inflammatory responses: implications for the development of probiotics. InfectImmun.
34. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J, (1994) Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 62: 2590-2599.
35. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, et al. (2008) CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nature immunology 9: 1253-1260.
36. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, et al. (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infection and immunity 76: 4726-4736.
37. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, et al. (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8: e1002995.
38. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT, (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227.
39. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, et al. (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461: 1282-1286.
40. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547.
41. Bansal T, Alaniz RC, Wood TK, Jayaraman A, (2010) The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proceedings of the National Academy of Sciences of the United States of America 107: 228-233.
42. Cario E, Gerken G, Podolsky DK, (2004) Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 127: 224-238.
43. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575.
44. Kim Y, Kim SH, Whang KY, Kim YJ, Oh S, (2008) Inhibition of Escherichia coli O157: H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. Journal of microbiology and biotechnology 18: 1278-1285.
45. Otte JM, Podolsky DK, (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. American journal of physiology Gastrointestinal and liver physiology 286: G613-626.
46. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von MB, Schlee M, et al. (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. InfectImmun 72: 5750-5758.
47. Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, et al. (2012) Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36: 276-287.
48. Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, et al. (2013) Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62: 220-226.
49. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL, (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
50. Fujiwara D, Wei B, Presley LL, Brewer S, McPherson M, et al. (2008) Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. Journal of immunology 180: 5843-5852.
51. Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, et al. (2009) NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 30: 289-299.
52. Contractor N, Louten J, Kim L, Biron CA, Kelsall BL, (2007) Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. Journal of immunology 179: 2690-2694.
53. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. JClinInvest 115: 695-702.
54. McFarland AP, Savan R, Wagage S, Addison A, Ramakrishnan K, et al. (2011) Localized delivery of interferon-beta by Lactobacillus exacerbates experimental colitis. PloS one 6: e16967.
55. Yen JH, Kong W, Ganea D, (2010) IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. Journal of immunology 184: 3478-3486.
56. Farache J, Koren I, Milo I, Gurevich I, Kim KW, et al. (2013) Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38: 581-595.
57. Ito T, Yang M, Wang YH, Lande R, Gregorio J, et al. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. JExpMed 204: 105-115.
58. Izcue A, Coombes JL, Powrie F, (2009) Regulatory lymphocytes and intestinal inflammation. Annual review of immunology 27: 313-338.
59. Belkaid Y, Tarbell K, (2009) Regulatory T cells in the control of host-microorganism interactions (*). Annual review of immunology 27: 551-589.
60. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, et al. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS biology 5: 2177-2189.
61. Ranatunga DC, Ramakrishnan A, Uprety P, Wang F, Zhang H, et al. (2012) A protective role for human IL-10-expressing CD4+ T cells in colitis. Journal of immunology 189: 1243-1252.
62. Muller A, Oertli M, Arnold IC, (2011) H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell communication and signaling: CCS 9: 25.
63. Hall AO, Beiting DP, Tato C, John B, Oldenhove G, et al. (2012) The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37: 511-523.
64. Turner JD, Jenkins GR, Hogg KG, Aynsley SA, Paveley RA, et al. (2011) CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS neglected tropical diseases 5: e1269.
65. Barnes PD, Bergman MA, Mecsas J, Isberg RR, (2006) Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. JExpMed 203: 1591-1601.